Microbix Reports Virology Revenue Up 8% in First Quarter
Marketwired - Fri Feb 13, 7:31AM CST
Microbix Biosystems Inc. (TSX: MBX), an innovator of biological products and technologies, today reported financial results for its first quarter ending December 31, 2014.
MBX.TO: 0.57 (-0.09)
IIROC Trade Resumption - Microbix Biosystems Inc.
Newsfile Corp - Fri Aug 22, 12:57PM CDT
Trading resumes in:
IIROC Trade Halt - Microbix Biosystems Inc.
Newsfile Corp - Fri Aug 22, 12:17PM CDT
The following issues have been halted by IIROC: